NCT02939495View on ClinicalTrials.gov

The Efficacy and Safety of Dapoxetine/Sildenafil Combination Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

August 31, 2017

Conditions
Premature EjaculationErectile Dysfunction
Interventions
DRUG

Dapoxetine/Sildenafil 30/50 mg film coated tablet

1 tablet before sexual intercourse

Trial Locations (1)

34100

Bagcilar Research and Training Hospital, Istanbul

All Listed Sponsors
lead

Neutec Ar-Ge San ve Tic A.Ş

INDUSTRY

NCT02939495 - The Efficacy and Safety of Dapoxetine/Sildenafil Combination Therapy | Biotech Hunter | Biotech Hunter